Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-080838
Filing Date
2025-04-15
Accepted
2025-04-15 08:35:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d935615d424b3.htm 424B3 17217
2 GRAPHIC g935615g0412034200929.jpg GRAPHIC 3244
  Complete submission text file 0001193125-25-080838.txt   23026
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 25837706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)